Article
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers
- Curanex Pharmaceuticals (NASDAQ:CURX) shares moved upwards by 57.7% to $0.5 during Thursday's regular session. The company's market cap stands at $8.9 million.
- Butterfly Network (NYSE:BFLY) shares rose 48.06% to $4.59. The company's market cap stands at $783.0 million. As per the press release, Q4 earnings came out today.
- Klotho Neurosciences (NASDAQ:KLTO) stock increased by 21.61% to $0.52. The market value of their outstanding shares is at $30.9 million.
- Healthcare Triangle (NASDAQ:HCTI) stock rose 20.91% to $7.03. The company's market cap stands at $4.3 million.
- LeMaitre Vascular (NASDAQ:LMAT) stock moved upwards by 19.06% to $108.8. The market value of their outstanding shares is at $2.0 billion. As per the news, the Q4 earnings report came out yesterday.
- PMV Pharma (NASDAQ:PMVP) shares rose 18.74% to $1.33. The market value of their outstanding shares is at $59.5 million.
Losers
- uniQure (NASDAQ:QURE) stock declined by 29.4% to $17.57 during Thursday's regular session. The company's market cap stands at $1.5 billion.
- PROCEPT BioRobotics (NASDAQ:PRCT) stock declined by 22.48% to $21.58. The market value of their outstanding shares is at $1.5 billion. As per the news, the Q4 earnings report came out yesterday.
- Bristol-Myers Squibb Company Celegne Contingent Value Rights (NYSE:CELGR) stock fell 20.46% to $0.08.
- Nautilus Biotechnology (NASDAQ:NAUT) stock fell 19.9% to $2.31. The market value of their outstanding shares is at $365.0 million. The company's, Q4 earnings came out today.
- 20/20 Biolabs (NASDAQ:AIDX) shares fell 19.02% to $4.6. The company's market cap stands at $58.7 million.
- GoodRx Holdings (NASDAQ:GDRX) stock fell 18.37% to $2.0. The market value of their outstanding shares is at $880.3 million. As per the press release, Q4 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Comments
- No comments yet. Be the first to comment!